ADAPTATE BIOTHERAPEUTICS LTD

Company number 12166787

Date	Type	Description	View / Download
26 Apr 2022	TM01	Termination of appointment of Christine Kim Ward as a director on 26 April 2022	(1 page)
26 Apr 2022	TM01	Termination of appointment of John Gerard Shields as a director on 26 April 2022	(1 page)
26 Apr 2022	TM01	Termination of appointment of Victor Stone as a director on 26 April 2022	(1 page)
26 Apr 2022	TM01	Termination of appointment of Timothy John Haines as a director on 26 April 2022	(1 page)
26 Apr 2022	TM01	Termination of appointment of Peter Neville Goodfellow as a director on 26 April 2022	(1 page)
26 Apr 2022	TM01	Termination of appointment of Natalie Marianne Mount as a director on 26 April 2022	(1 page)
26 Apr 2022	AP03	Appointment of Mr Bryan Driscoll as a secretary on 26 April 2022	(2 pages)
26 Apr 2022	AP01	Appointment of Mr Mark Gibbons as a director on 26 April 2022	(2 pages)
09 Jan 2022	SH06	Cancellation of shares. Statement of capital on 9 December 2021 GBP 5,267.262	(7 pages)
09 Jan 2022	SH03	Purchase of own shares.	(3 pages)
08 Jan 2022	RESOLUTIONS	Resolutions RES13 ‐ Purchase by the company of 4158 growth shares of £0.01 each 09/12/2021	(6 pages)
28 Sep 2021	CS01	Confirmation statement made on 20 August 2021 with updates	(8 pages)
16 Sep 2021	SH01	Statement of capital following an allotment of shares on 8 September 2021 GBP 5,271.42	(4 pages)
16 Sep 2021	AP01	Appointment of Dr Victor Stone as a director on 1 September 2021	(2 pages)
16 Sep 2021	TM01	Termination of appointment of Loic Vincent as a director on 20 August 2021	(1 page)
26 Jul 2021	RESOLUTIONS	Resolutions RES13 ‐ Buyback agreement 23/06/2021 RES01 ‐ Resolution of alteration of Articles of Association	(9 pages)
23 Jul 2021	AA	Accounts for a small company made up to 31 March 2021	(11 pages)
16 Jul 2021	SH06	Cancellation of shares. Statement of capital on 30 June 2021 GBP 5,097.407	(7 pages)
16 Jul 2021	SH03	Purchase of own shares.	(3 pages)
13 Jul 2021	MA	Memorandum and Articles of Association	(38 pages)
17 May 2021	SH01	Statement of capital following an allotment of shares on 11 May 2021 GBP 5,105.226	(4 pages)
15 Apr 2021	SH01	Statement of capital following an allotment of shares on 15 April 2021 GBP 4,875.756	(4 pages)
14 Apr 2021	AP01	Appointment of Christine Kim Ward as a director on 6 April 2021	(2 pages)
12 Apr 2021	TM01	Termination of appointment of Daniel Matthew Kemp as a director on 6 April 2021	(1 page)
12 Apr 2021	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(8 pages)